Gynecologic Cancer
Conference Coverage
‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer
Efficacy was poorer in node-positive and high-risk patients.
Conference Coverage
Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?
The procedure may not be associated with peritoneal cytology at the time of surgical staging or with decreased survival.
Perspectives
COVID-19 vaccines and cancer patients: 4 things to know
Feature
NHS England starts pilot trial of blood test for many cancers
Patients with head and neck, pancreatic, and other hard-to-spot cancers could soon have their disease picked up early with a simple blood test if...
From the Journals
Cancer rates on the rise in adolescents and young adults
Conference Coverage
Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy
The likelihood of recurrence at certain sites and the timing of recurrence may relate to the surgical approach.
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
From the Journals
New findings on ‘exceptional responders’ to cancer therapies
Why do a small percentage of cancer patients show exceptional responses to therapy? The answer may lie in their genetic makeup.
From the Journals
Half of women treated for gynecologic cancers miss or skip doses of oral drugs
Those who did not take all their medications cited anxiety or expressed doubt about the efficacy of their regimens.
From the Journals
Two-drug combo should be first-line standard of care in advanced endometrial cancer
Survival outcomes for the combination paclitaxel-carboplatin were similar to those with paclitaxel, doxorubicin, and cisplatin but with lower...
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.